APA (7th ed.) Citation

R, F., M, G., R, G., UA, W., L, J., W, U., . . . H, O. (2025). Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 43(30), 3266. https://doi.org/10.1200/JCO-24-01502

Chicago Style (17th ed.) Citation

R, Fietkau, et al. "Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 43, no. 30 (2025): 3266. https://doi.org/10.1200/JCO-24-01502.

MLA (9th ed.) Citation

R, Fietkau, et al. "Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 43, no. 30, 2025, p. 3266, https://doi.org/10.1200/JCO-24-01502.